Article

De Novo Design and Bioactivity Prediction of SARS-CoV-2 Main Protease Inhibitors Using ULMFit

2020-10-14

Abstract excerpt

<title>Abstract</title> <p>The global pandemic of coronavirus disease (COVID-19) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) created a rush to discover drug candidates. Despite the efforts, so far no vaccine or drug has been approved for treatment. Artificial intelligence offers solutions that could accelerate the discovery and optimization of new antivirals, especially in the current s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 409bc175-6241-50fe-9420-e2dbc2dd803d
DOI: 10.21203/rs.3.rs-90793/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

De Novo Design and Bioactivity Prediction of SARS-CoV-2 Main Protease Inhibitors Using ULMFitDOI 10.21203/rs.3.rs-90793/v1Read

A Novel de novo Design Study of Potent SARS-CoV-2 Main Protease Inhibitors Based on Reinforcement Learning and Molecular DockingSemantic proximity Read

Discovery of novel quinoline papain-like protease inhibitors for COVID-19 through topology constrained molecular generative modelSemantic proximity Read

Potential Non-Covalent SARS-CoV-2 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches and Reviewed by Human Medicinal Chemist in Virtual RealitySemantic proximity Read

New Potential Drug Candidates Against SARS-CoV-2 Using Generative ModelSemantic proximity Read

AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2Semantic proximity Read

Combined Deep Learning and Molecular Docking Simulations Approach Identifies Potentially Effective FDA Approved Drugs for Repurposing Against SARS-CoV-2Semantic proximity Read

Fleming: An AI Agent for Antibiotic Design for Mycobacterium tuberculosisSemantic proximity Read

Deep Molecular Generative Model Based on Variant Transformer for Antiviral Drug DesignSemantic proximity Read

A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanismSemantic proximity Read

Structure-free, site-resolved contrastive learning extends small-molecule discovery beyond the reach of structure-based modelingSemantic proximity Read

Repurposing drugs for treatment of SARS-CoV-2 infection: Computational design insights into mechanisms of actionSemantic proximity Read

Generative AI-assisted Virtual Screening Pipeline for Generalizable and Efficient Drug RepurposingSemantic proximity Read